Edwards Lifesciences (NYSE: EW) announced that its board of directors approved a two-for-one split of the company's outstanding shares of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE